The full text of this article


Interaction of curcumin with different target proteins of Alzheimer's disease: docking and MD simulation studies
by Shraddha Sriraman; Nanda Gopal Saha; Sujata Roy
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 10, No. 4, 2017


Abstract: Curcumin, commonly called turmeric has been extensively used in the treatment of various medical conditions, including arthritis, cystic fibrosis, cancer, Alzheimer's disease (AD) and so on. Although the effect of curcumin with regards to AD has been studied experimentally, the molecular mechanism is still unknown. Many targets of AD have been identified. In this analysis, the interactions of curcumin with eight different targets of AD have been studied, in order to locate the binding site of curcumin. Based on docking energy, three potential targets such as acetylcholinesterase, cholinesterase and inducible nitric oxide synthase have been selected. Then, MD simulation was performed for those three docked structures. It was found that acetylcholinesterase was the best target of curcumin. Existing experimental results support this finding. The dynamics of interaction at the atomic level was studied to understand the main chemical property of curcumin that can be exploited in treating AD.

Online publication date: Tue, 14-Nov-2017


is only available to individual subscribers or to users at subscribing institutions.

Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:


    Username:        Password:         

Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email